Tag Archives: Studies later show that South Africa has stopped the AstraZeneca vaccine rollout – it offers less protection against the CNN variant.

During a briefing on Sunday, South African Health Minister Dr. Zwelle McIze said the grip would be temporary as scientists figured out how to administer the AstraZeneca vaccine most effectively. Mkhaiz said South Africa would go ahead with the configuration of the vaccines developed by Pfizer / Bioentech and Johnson …

Read More »